Medical research and development service
Ended Purchase Order Awarded Last action
- Contract number
- N0018924PZ374
- Awardee
-
Pathoseq Bio, LLC UEI XZBGAKEK7K55
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $247,866
Award facts
- Opportunity
-
- AN42 - Health Research and Development Services Solicitation · N0018924QZ258 · Posted Jun 5, 2024
- Contract value 100% obligated
- $247,866.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- United States Minor Outlying Islands
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $247,866 |
About this award
The Department of the Navy's Bureau of Medicine and Surgery awarded a $247,866 firm fixed-price purchase order to Pathoseq Bio, LLC on July 1, 2024, for medical research and development services. This contract, set aside for total small business participation, is scheduled for completion by September 30, 2025, and will be performed in the United States Minor Outlying Islands. The award resulted from Solicitation AN42, issued by Naval Supply Systems Command, which sought health research and development services from qualified small business contractors. Pathoseq Bio, a specialized biological research firm registered as a small business in SAM.gov, was selected to deliver these services.
Pathoseq Bio brings relevant expertise to this engagement, having established a track record with the Navy's Bureau of Medicine and Surgery on similar medical research and biotechnology initiatives. The company specializes in advanced biological research, genomic analysis, and biothreat detection services, with previous contract awards demonstrating capabilities in sequence-based analysis and characterization of biological threats. This contract represents continued federal confidence in Pathoseq Bio's technical capabilities to support Navy medical research objectives and aligns with the Department of Defense's ongoing investment in biodefense and medical research capabilities.
Quick answers
Who was awarded contract N0018924PZ374?
N0018924PZ374 was awarded to Pathoseq Bio, LLC by Naval Supply Systems Command (Department of the Navy) on July 1, 2024.
How much is contract N0018924PZ374 worth?
The government has obligated $247,866 on N0018924PZ374.
Which agency awarded contract N0018924PZ374?
Naval Supply Systems Command (Department of the Navy) awarded N0018924PZ374, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Was contract N0018924PZ374 competed?
The extent of competition for N0018924PZ374 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award